Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MTCO2P33 (mitochondrially encoded cytochrome c oxidase II pseudogene 33) is classified as a pseudogene and is not a protein-coding gene. Pseudogenes are segments of DNA that closely resemble functional genes but are generally non-functional due to mutations or other disruptions in their sequences. MTCO2P33 is related by sequence to the functional mitochondrial gene MT-CO2, which encodes the cytochrome c oxidase subunit 2 of the mitochondrial respiratory chain. However, as a pseudogene, MTCO2P33 does not encode an active protein and has no established role as a receptor, enzyme, transporter, or another typical therapeutic target. There is no evidence to suggest biological function, involvement in disease, or interaction with drugs for this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded cytochrome c oxidase II pseudogene 33 (MTCO2P33).